-
1 Comment
AK Medical Holdings Limited is currently in a long term downtrend where the price is trading 8.5% below its 200 day moving average.
From a valuation standpoint, the stock is 91.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.2.
AK Medical Holdings Limited's total revenue rose by 13.8% to $556M since the same quarter in the previous year.
Its net income has increased by 10.0% to $151M since the same quarter in the previous year.
Finally, its free cash flow grew by 187.8% to $73M since the same quarter in the previous year.
Based on the above factors, AK Medical Holdings Limited gets an overall score of 4/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
ISIN | KYG020141019 |
CurrencyCode | HKD |
Exchange | HK |
Dividend Yield | 0.6% |
---|---|
Target Price | 11.8 |
Beta | -0.87 |
PE Ratio | 100.55 |
Market Cap | 12B |
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1789.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024